Emerging targeted therapies for melanoma treatment (review).

Abstract:

:Cutaneous melanoma is an aggressive cancer with a poor prognosis for patients with advanced disease. The identification of several key molecular pathways implicated in the pathogenesis of melanoma has led to the development of novel therapies for this devastating disease. In melanoma, both the Ras/Raf/MEK/ERK (MAPK) and the PI3K/AKT (AKT) signalling pathways are constitutively activated through multiple mechanisms. Targeting various effectors of these pathways with pharmacologic inhibitors may inhibit melanoma cell growth and angiogenesis. Ongoing clinical trials provide hope to improve progression-free survival of patients with advanced melanoma. This review summarizes the most relevant studies focused on the specific action of these new molecular targeted agents. Mechanisms of resistance to therapy are also discussed.

journal_name

Int J Oncol

authors

Russo A,Ficili B,Candido S,Pezzino FM,Guarneri C,Biondi A,Travali S,McCubrey JA,Spandidos DA,Libra M

doi

10.3892/ijo.2014.2481

subject

Has Abstract

pub_date

2014-08-01 00:00:00

pages

516-24

issue

2

eissn

1019-6439

issn

1791-2423

journal_volume

45

pub_type

杂志文章,评审
  • Evaluation of chemotherapeutic and cancer-protective properties of sphingosine and C2-ceramide in a human breast stem cell derived carcinogenesis model.

    abstract::The overall goal of the present study was to evaluate the chemotherapeutic and cancer‑protective properties of D‑erythro‑sphingosine (sphingosine) and C2‑ceramide using a human breast epithelial cell (HBEC) culture system, which represents multiple‑stages of breast carcinogenesis. The HBEC model includes Type I HBECs ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4641

    authors: Ahn EH,Yang H,Hsieh CY,Sun W,Chang CC,Schroeder JJ

    更新日期:2019-02-01 00:00:00

  • Paeonol suppresses lipid accumulation in macrophages via upregulation of the ATP‑binding cassette transporter A1 and downregulation of the cluster of differentiation 36.

    abstract::Paeonol, a potent antioxidant isolated from cortex moutan, possesses athero‑protective activity, yet the detailed mechanisms are not fully investigated. This study was conducted to explore the role of paeonol and its underlying mechanisms in RAW264.7 macrophages and apolipoprotein E‑deficient (ApoE(‑/‑)) mice. Paeonol...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2757

    authors: Li X,Zhou Y,Yu C,Yang H,Zhang C,Ye Y,Xiao S

    更新日期:2015-02-01 00:00:00

  • Prostate cancer as an environmental disease: an ecological study in the French Caribbean islands, Martinique and Guadeloupe.

    abstract::Using a transdisciplinary methodological approach we have conducted a multifactorial analysis in Martinique and Guadeloupe in order to elucidate the aetiology of prostate cancer. In 2002, world age standardized rates of prostate cancer were 152 new cases per 100,000 person-years in the two islands; one of the highest ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo_00000229

    authors: Belpomme D,Irigaray P,Ossondo M,Vacque D,Martin M

    更新日期:2009-04-01 00:00:00

  • CD26: a novel treatment target for T-cell lymphoid malignancies? (Review).

    abstract::CD26 is a surface glycoprotein with intrinsic dipeptidyl peptidase IV (DPPIV) enzyme activity with multiple biological roles, including being intricately involved in immunoregulation as a T-cell activation molecule and as a regulator of chemokine function. T-cell lymphoid malignancies represent a heterogeneous group o...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Sato K,Dang NH

    更新日期:2003-03-01 00:00:00

  • Histone deacetylase 3 promotes pancreatic cancer cell proliferation, invasion and increases drug-resistance through histone modification of P27, P53 and Bax.

    abstract::Pancreatic cancer is one of the most aggressive solid malignancies with a dismal survival rate. Recent studies have shown that high expression levels of histone deacetylase 3 (HDAC3) correlate with malignant phenotype. However, the expression patterns and biological role of HDAC3 in pancreatic cancer remain unclear. I...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2568

    authors: Jiao F,Hu H,Yuan C,Jin Z,Guo Z,Wang L,Wang L

    更新日期:2014-10-01 00:00:00

  • P53 and its implication in apoptosis (review).

    abstract::The tumor suppressor protein p53 is one of the most important manipulators of the cell cycle. By interaction with targets such as WAF1/CIP1, mdm2 or GADD45 p53 functions as a negative or positive regulator of the cell cycle. After DNA damage p53 is implicated in growth arrest of cells in the G(1) phase of the cell cyc...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.6.5.1129

    authors: Gotz C,Montenarh M

    更新日期:1995-05-01 00:00:00

  • The p53-positive phenotype of breast cancers.

    abstract::One hundred and eighty-one breast cancer specimens were analyzed for nuclear p53 staining by immunochemical methods. There were 123 fine-needle cytological specimens and 58 frozen tissue sections of surgical biopsies. The microscopic evaluation of the staining fitted with a 4 group classification. Ninety-one samples (...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.10.4.747

    authors: Lesec G,Richardcoulet E,Collet J,Demaublanc M,Merle S,Salmon R,Remvikos Y

    更新日期:1997-04-01 00:00:00

  • Bioflavonoids, type II [H-3]estradiol binding sites and prostatic cancer cell proliferation.

    abstract::Previous studies from this laboratory have shown that bioflavonoids including luteolin and quercetin possess antiestrogenic activity in the female reproductive tract and appear to elicit this activity by interaction with type II [H-3]estradiol binding sites in the cell nucleus. Studies by a number of laboratories incl...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.11.6.1311

    authors: Markaverich B,Alejandro M

    更新日期:1997-12-01 00:00:00

  • CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1.

    abstract::Lung cancer is the most common and most lethal type of cancer. A sustained proliferative capacity is one of the hallmarks of cancer, and microtubules serve an important role in maintaining a sustained cell cycle. Therefore, understanding the regulation of microtubule proteins in the cell cycle is important for tumor p...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4805

    authors: Shan L,Zhao M,Lu Y,Ning H,Yang S,Song Y,Chai W,Shi X

    更新日期:2019-07-01 00:00:00

  • High-frequency of loss of expression and allelic deletion of the apc and mcc genes in human prostate-cancer.

    abstract::Loss of heterozygosity (LOH) or allelic deletion at various loci has been reported in the majority of human tumors. The frequently deleted targets are believed to be tumor suppressor genes. Recent studies have identified the APC and MCC genes at 5q21, as putative tumor suppressor genes. The APC and MCC genes have been...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.6.1.111

    authors: Gao X,Zacharek A,Grignon D,Liu H,Sakr W,Porter A,Chen Y,Honn K

    更新日期:1995-01-01 00:00:00

  • Chemoprevention of azoxymethane-induced rat colon carcinogenesis by dietary capsaicin and rotenone.

    abstract::The modifying effects of dietary administration of capsaicin, which is the principal pungent capsicum fruit, and rotenone, which is a naturally occurring pesticide derived from Derris and Lonchorcarpus species, on azoxymethane (AOM)-induced colon tumorigenesis were investigated in male F344 rats. Gavage with capsaicin...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.19.5.929

    authors: Yoshitani SI,Tanaka T,Kohno H,Takashima S

    更新日期:2001-11-01 00:00:00

  • Aminopeptidase A expression and enzymatic activity in primary human renal cancers.

    abstract::The gp160 human kidney differentiation antigen is identical to human aminopeptidase A (APA), a zinc-dependent cell-surface metallopeptidase which hydrolyzes peptides with N-terminal acidic residues. GP160/APA is constitutively expressed by proximal tubule cells, the normal cellular counterpart of most renal cancers (R...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.13.2.261

    authors: Nanus DM,Bogenrieder T,Papandreou CN,Finstad CL,Lee A,Vlamis V,Motzer RJ,Bander NH,Albino AP,Reuter VE

    更新日期:1998-08-01 00:00:00

  • Dysfunction of p53 pathway in human colorectal cancer: analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2.

    abstract::Mutations of p53 tumor suppressor gene increase with tumor progression in colorectal cancers. In this study, we examined the expressions of p33ING1, p14ARF, MDM2 and p21WAF1 mRNA in 25 advanced colorectal cancers by quantitative RT-PCR method, and compared the expression levels of p33ING1, p14ARF, p21WAF1 and MDM2 in ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Tachibana M,Kawamata H,Fujimori T,Omotehara F,Horiuchi H,Ohkura Y,Igarashi S,Kotake K,Kubota K

    更新日期:2004-10-01 00:00:00

  • Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review).

    abstract::On the basis of immunological results, it is not in doubt that the immune system is able to recognize and eliminate transformed cells. A plethora of studies have investigated the immune system of patients with cancer and how it is prone to immunosuppression, due in part to the decrease in lymphocyte proliferation and ...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.2018.4283

    authors: Scutti JAB

    更新日期:2018-04-01 00:00:00

  • Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin.

    abstract::Chemotherapy is an established treatment modality for bone sarcomas such as osteosarcoma (OS). However, the use of chemotherapy in high-grade soft tissue sarcomas remains controversial, with the most active chemotherapeutic agent, doxorubicin (DOX), reported to have a response rate of, at best only 34% and most studie...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.24.5.1263

    authors: Bouralexis S,Clayer M,Atkins GJ,Labrinidis A,Hay S,Graves S,Findlay DM,Evdokiou A

    更新日期:2004-05-01 00:00:00

  • IMP-3 protects the mRNAs of cyclins D1 and D3 from GW182/AGO2-dependent translational repression.

    abstract::IGF-2 mRNA binding protein 3 (IGF2BP3, IMP-3) is a well-known post-transcriptional regulatory factor of gene expression, mainly involved in embryonic development and oncogenesis. We have previously demonstrated that a subset of IMP-3 targets, such as the mRNAs of cyclins D1, D3 and G1, are positively regulated by IMP-...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3750

    authors: Deforzh E,Vargas TR,Kropp J,Vandamme M,Pinna G,Polesskaya A

    更新日期:2016-12-01 00:00:00

  • Induction of differentiation accompanies inhibition of Cdk2 in a non-small cell lung cancer cell line.

    abstract::Induction of differentiation in a variety of model systems is accompanied by cell cycle exit and inhibition of Cdk2 kinase activity. We asked whether inhibition of Cdk2 activity is sufficient to allow differentiation to occur in a non-small cell lung cancer cell line. Treatment of NCI-H358 with flavopiridol, an inhibi...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Lee HR,Chang TH,Tebalt MJ 3rd,Senderowicz AM,Szabo E

    更新日期:1999-07-01 00:00:00

  • Production and characterization of a monoclonal antibody (MSN-3) for uterine endometrial and endocervical adenocarcinoma.

    abstract::A monoclonal antibody (MSN-3) was raised using HEC-108 cells derived from poorly differentiated endometrial carcinoma as the immunogen. The immunoglobulin subclass of MSN-3 was IgGr1. The target antigen of MSN-3 was a protein with a molecular weight of 77 kDa, and it was shown to be localized in the cytoplasm. MSN-3 o...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.11.4.749

    authors: Hasegawa K,Tsukazaki K,Kubushiro K,Kobayashi Y,Kobiki K,Udagawa Y,Nozawa S

    更新日期:1997-10-01 00:00:00

  • Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.

    abstract::Chemokine-mediated activation of G protein-coupled receptors CXCR1/2 promotes tumor growth, invasion, inflammation and metastasis. Repertaxin, a CXCR1/2 small-molecule inhibitor, has been shown to attenuate many of these tumor-associated processes. The present study aimed to investigate the effects of repertaxin alone...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3371

    authors: Wang J,Hu W,Wang K,Yu J,Luo B,Luo G,Wang W,Wang H,Li J,Wen J

    更新日期:2016-04-01 00:00:00

  • Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use.

    abstract::Genetically engineered stem cells (GESTECs) producing suicide enzymes and immunotherapeutic cytokines have therapeutic effects on tumors, and may possibly reduce the side effects of toxic drugs used for treatments. Suicide enzymes can convert non-toxic pro-drugs to toxic metabolites that can reduce tumor growth. Cytos...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1288

    authors: Kim KY,Yi BR,Lee HR,Kang NH,Jeung EB,Kim SU,Choi KC

    更新日期:2012-04-01 00:00:00

  • Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells.

    abstract::The MUC1 heterodimeric protein is aberrantly overexpressed in diverse human carcinomas and contributes to the malignant phenotype. The MUC1-C transmembrane subunit contains a CQC motif in the cytoplasmic domain that has been implicated in the formation of dimers and in its oncogenic function. The present study demonst...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1308

    authors: Raina D,Ahmad R,Rajabi H,Panchamoorthy G,Kharbanda S,Kufe D

    更新日期:2012-05-01 00:00:00

  • Application of RT-PCR to clinical diagnosis of micrometastasis of colorectal cancer: A translational research study.

    abstract::We previously reported in a retrospective study that CEA-based RT-PCR was useful for predicting the prognosis of patients with node-negative colorectal cancer. RT-PCR is well established for laboratory use, but many issues remain to be resolved prior to its clinical application. In addition to the false positive rate ...

    journal_title:International journal of oncology

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Takayama O,Yamamoto H,Ikeda K,Ishida H,Kato T,Okuyama M,Kanou T,Fukunaga M,Tominaga S,Morita S,Fujie Y,Fukunaga H,Ikenaga M,Ikeda M,Ohue M,Sekimoto M,Kikkawa N,Monden M

    更新日期:2004-09-01 00:00:00

  • Methylation status of the SOCS3 gene in human malignant melanomas.

    abstract::The suppressors of cytokine signaling (SOCS) family inhibits not only Janus kinase (JAK)/signal transducers and activators of transcription (STAT) but also focal adhesion kinase (FAK) signaling pathways, and has tumor suppressor activity. Aberrant methylation in the promoter region of the SOCS3 gene frequently occurs ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Tokita T,Maesawa C,Kimura T,Kotani K,Takahashi K,Akasaka T,Masuda T

    更新日期:2007-03-01 00:00:00

  • In vitro reversion of transformed phenotype in mouse C3H/10T1/2 cells.

    abstract::Spontaneous tumor regression is still one of the most puzzling events in human cancer. A cell culture model of malignant transformation designed to permit the study of this phenomenon in vitro was applied to examine reversion and re-expression of the transformed phenotype in two X-ray transformed mouse 10T1/2 cell clo...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.8.4.727

    authors: Paquette B,Wagner R,Little J

    更新日期:1996-04-01 00:00:00

  • A cisplatin‑incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity.

    abstract::Radiotherapy (RT) is one of the major modalities for non‑small cell lung cancer (NSCLC), but its efficacy is often compromised by cellular resistance caused by various mechanisms including the overexpression of epidermal growth factor receptor (EGFR). Although cis‑diamminedichloroplatinum(Ⅱ) (cisplatin, CDDP) has been...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2806

    authors: Jung J,Jeong SY,Park SS,Shin SH,Ju EJ,Choi J,Park J,Lee JH,Kim I,Suh YA,Hwang JJ,Kuroda S,Lee JS,Song SY,Choi EK

    更新日期:2015-03-01 00:00:00

  • alpha2beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity.

    abstract::Tumor cell invasion and metastasis requires precise coordination of adherence to the extracellular matrix (ECM) and controlled degradation of its components. lnvasive cells secrete proteolytic enzymes known as matrix metalloproteinases which degrade specific basement membrane molecules. Expression of these enzymes is ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.13.6.1127

    authors: Vo HP,Lee MK,Crowe DL

    更新日期:1998-12-01 00:00:00

  • VEGF in nuclear medicine: Clinical application in cancer and future perspectives (Review).

    abstract::Clinical trials using antiangiogenic drugs revealed their potential against cancer. Unfortunately, a large percentage of patients does not yet benefit from this therapeutic approach highlighting the need of diagnostic tools to non-invasively evaluate and monitor response to therapy. It would also allow to predict whic...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.2016.3553

    authors: Taurone S,Galli F,Signore A,Agostinelli E,Dierckx RA,Minni A,Pucci M,Artico M

    更新日期:2016-08-01 00:00:00

  • The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.

    abstract::The ADAMs (A disintegrin and metalloproteinase) are a family of cell-surface membrane glycoproteins, whose multidomain structure enables diverse roles in a wide range of cellular processes. Accumulating evidence associates an increased expression of individual ADAM family members with various types of cancer, and we i...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Carl-McGrath S,Lendeckel U,Ebert M,Roessner A,Röcken C

    更新日期:2005-01-01 00:00:00

  • Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells.

    abstract::Sorafenib is currently used to treat advanced and/or unresectable hepatocellular carcinoma (HCC), but the increase of the median survival was only 3 months. Moreover, sorafenib has severe side effects and patients develop resistance quickly. Epigenetic alterations such as DNA methylation play a decisive role in the de...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2017.4019

    authors: Abeni E,Salvi A,Marchina E,Traversa M,Arici B,De Petro G

    更新日期:2017-07-01 00:00:00

  • Prostate-cancer surveillance - a cost-effective strategy.

    abstract::The intention of a surveillance program to monitor prostate cancer patients is to detect recurrence of disease as soon as possible and institute therapy at the time of recurrence in order to improve the chance of cure or extend survival. We analyzed the cost of four surveillance programs for prostate cancer. As PSA le...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2.3.473

    authors: Schapira D,Jarrett A

    更新日期:1993-03-01 00:00:00